Tehmina S. Khan

Accounting · 2006–2021

A researcher in the Science corpus: 2 papers; trusts 3 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

Whom Tehmina S. Khan trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Stephen R. Bond
  2. F. Windmeijer
  3. Badi H. Baltagi
  4. Luc Renneboog

Who trusts Tehmina S. Khan overall

  1. Yordying Thanatawee
  2. Chris Florackis

Papers from Tehmina S. Khan's perspective

Ordered by how strongly the researchers Tehmina S. Khan trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials. (Journal of the American Medical Association (JAMA))
  2. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine (New England Journal of Medicine)
  3. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial (Lancet. Infectious Diseases (Print))
  4. Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization (Nature)
  5. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2 (Cell)
  6. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants (Nature)
  7. Dividend Policy, Corporate Governance and the Managerial Entrenchment Hypothesis: An Empirical Analysis
  8. THE ESTIMATION OF ECONOMIC RELATIONSHIPS USING INSTRUMENTAL VARIABLES
  9. Orthogonal Parameters and Panel Data
  10. A Finite Sample Correction for the Variance of Linear Two-Step GMM Estimators

Their papers